Somerville, MA, United States of America

Vidya Subramanian

USPTO Granted Patents = 15 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.9

ph-index = 6

Forward Citations = 73(Granted Patents)

Location History:

Somerville, MA (US) (2014 - 2021)
Cambridge, MA (US) (2022)
Concord, MA (US) (2021 - 2024)

Company Filing History:

10 out of 8,369

Massachusetts Institute of Technology

The Broad Institute, Inc.

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12024552 - Ha binding agents (2024-07-02),

2. 11459405 - Bispecific antibodies having constant region mutations and uses therefor (2022-10-04),

3. 11414701 - Multimodal readouts for quantifying and sequencing nucleic acids in single cells (2022-08-16),

4. 10947300 - Agents for influenza neutralization (2021-03-16),

5. 10894818 - Antibodies that bind Ebola glycoprotein and uses thereof (2021-01-19),

6. 10800835 - HA binding agents (2020-10-13),

7. 10538578 - Agents for influenza neutralization (2020-01-21),

8. 9982037 - Agents for influenza neutralization (2018-05-29),

9. 9969794 - HA binding agents (2018-05-15),

10. 9683030 - Agents for influenza neutralization (2017-06-20),

11. 9572861 - Engineered polypeptide agents for targeted broad spectrum influenza neutralization (2017-02-21),

12. 9334309 - Engineered polypeptide agents for targeted broad spectrum influenza neutralization (2016-05-10),

13. 9096657 - HA binding agents (2015-08-04),

14. 8877200 - HA binding agents (2014-11-04),

15. 8637456 - Engineered polypeptide agents for targeted broad spectrum influenza neutralization (2014-01-28),

Title: Innovator Vidya Subramanian: A Leader in Antibody Development

Introduction

Vidya Subramanian, based in Somerville, MA, is a distinguished inventor known for her groundbreaking contributions in the field of biopharmaceuticals. With a remarkable portfolio of 15 patents, she has made significant advancements in antibody technology, particularly in combating influenza viruses and improving bispecific antibodies.

Latest Patents

Subramanian's latest innovations include two notable patents. The first is related to novel peptide agents that bind to the hemagglutinin protein of influenza viruses. These antibodies and antigen-binding fragments offer promising methods for treating and preventing influenza infections. The second patent details mutations in the constant regions of bispecific antibodies, enhancing their heterodimerization capability. This development facilitates the efficient production of bispecific antibodies, paving the way for new therapeutic and diagnostic applications.

Career Highlights

Throughout her career, Vidya has been associated with prestigious organizations, including the Massachusetts Institute of Technology and Visterra, Inc. Her work at these institutions has been instrumental in advancing research and innovation in antibody engineering.

Collaborations

Subramanian has collaborated with several prominent figures in the biopharmaceutical sector, including Ram Sasisekharan and Karthik Viswanathan. These collaborations have fostered a spirit of innovation and have contributed to her success in developing new technologies.

Conclusion

With her extensive patent portfolio and significant contributions to the field of antibody research, Vidya Subramanian has established herself as a leading innovator. Her work continues to impact the development of therapeutic solutions for complex diseases, showcasing the importance of innovation in biomedicine.

This text is generated by artificial intelligence and may not be accurate.